Impact of Thyroid Dysregulation on Glycemic Control in Type 2 Diabetes Mellitus: A Comparative Investigation

Authors

  • Farmanullah Lecturer Medical Laboratory Technology, Riphah International University, Islamabad, Pakistan.
  • Hayat Ur Rahman Lecturer Medical Laboratory Technology, Riphah International University, Islamabad, Pakistan.
  • Naseem Khan MS MLS, Riphah International University, Islamabad, Pakistan.
  • Asad Ullah MS MLS, Riphah International University, Islamabad, Pakistan.
  • Waseem Abbas Lecturer Medical Laboratory Technology, Riphah International University, Islamabad, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i2.738

Keywords:

Diabetes Mellitus, Thyroid Dysfunction, Hyperthyroidism, Hypothyroidism, HbA1c, Prevalence, Type 2 Diabetes

Abstract

Background: Diabetes mellitus (DM) and thyroid dysfunction (TD) are among the most prevalent endocrine disorders globally, with a complex bidirectional relationship. Thyroid hormones play a pivotal role in regulating carbohydrate metabolism and pancreatic function. This study investigates the prevalence and patterns of thyroid dysfunction in patients with type 2 diabetes mellitus (T2DM) compared to a non-diabetic control group. Methods: A descriptive and comparative study was conducted at Al-Sehat Hospital, Timergara, Lower Dir, involving 330 participants divided into two groups: non-diabetic controls (n=165) and confirmed T2DM patients (n=165). Blood samples were analyzed for thyroid function tests (TFTs) and glycated hemoglobin (HbA1c) using automated analyzers. Data were analyzed using SPSS version 22, with results expressed as frequencies, percentages, and descriptive statistics. Results: Thyroid dysfunction was observed in 20% of T2DM patients, significantly higher than the 8.43% in the control group. Among diabetic patients, hyperthyroidism (14.54%) was more prevalent than hypothyroidism (5.46%). Females were disproportionately affected, constituting 84.84% of diabetic cases with T2DM. Age was a significant factor, with higher T2DM prevalence in individuals over 40 years. Mean HbA1c in diabetic patients was 9.84±3.385, reflecting poor glycemic control. Conclusion: The study highlights a significantly higher prevalence of thyroid dysfunction in T2DM patients compared to non-diabetic individuals, with hyperthyroidism being the most common abnormality. Routine screening for thyroid dysfunction, particularly in high-risk groups, is essential for timely diagnosis and management to mitigate complications.

Downloads

Download data is not yet available.

References

Chauhan, A., & Patel, S. S. (2024). Thyroid hormone and diabetes mellitus interplay: Making management of comorbid disorders complicated. Hormone and Metabolic Research, 56(12), 845-858. https://doi.org/10.1055/a-2374-8756

Alam, S., Hasan, M. K., Neaz, S., Hussain, N., Hossain, M. F., & Rahman, T. (2021). Diabetes mellitus: Insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetology, 2(2), 36-50. https://doi.org/10.3390/diabetology2020004

Eom, Y. S., Wilson, J. R., & Bernet, V. J. (2022). Links between thyroid disorders and glucose homeostasis. Diabetes & Metabolism Journal, 46(2), 239-256. https://doi.org/10.4093/dmj.2022.0013

Bhardwaj, S., & Yadav, S. (2021). Thyroid physiology. Endocrine Surgery, 2-9. https://doi.org/10.1201/9780429197338-2

Hsieh, Y. (2023). Safety of Antithyroid drugs in avoiding hyperglycemia or hypoglycemia in patients with Graves’ disease and type 2 diabetes mellitus: A literature review. Cureus. https://doi.org/10.7759/cureus.41017

Chauhan, A., & Patel, S. S. (2024). Thyroid hormone and diabetes mellitus interplay: Making management of comorbid disorders complicated. Hormone and Metabolic Research, 56(12), 845-858. https://doi.org/10.1055/a-2374-8756

Wang, X., Zhang, W., & Zhou, S. (2024). Multifaceted physiological and therapeutical impact of curcumin on hormone‐related endocrine dysfunctions: A comprehensive review. Phytotherapy Research, 38(7), 3307-3336. https://doi.org/10.1002/ptr.8208

Yang, K. (2024). Ketone Body Metabolism in Obesity and Diabetes.

Pinto, S., Croce, L., Carlier, L., Cosson, E., & Rotondi, M. (2023). Thyroid dysfunction during gestation and gestational diabetes mellitus: A complex relationship. Journal of Endocrinological Investigation, 46(9), 1737-1759. https://doi.org/10.1007/s40618-023-02079-3

Capuccio, S., Scilletta, S., La Rocca, F., Miano, N., Di Marco, M., Bosco, G., Di Giacomo Barbagallo, F., Scicali, R., Piro, S., & Di Pino, A. (2024). Implications of GLP-1 receptor agonist on thyroid function: A literature review of its effects on thyroid volume, risk of cancer, functionality and TSH levels. Biomolecules, 14(6), 687. https://doi.org/10.3390/biom14060687

Łukawska-Tatarczuk, M. M., Zieliński, J., Franek, E., Czupryniak, L., & Mrozikiewicz-Rakowska, B. (2022). Is thyroid autoimmunity associated with subclinical atherosclerosis in young women with type 1 diabetes mellitus? Endokrynologia Polska, 73(2), 301-308. https://doi.org/10.5603/ep.a2022.0018

Tomic, D., Harding, J. L., Jenkins, A. J., Shaw, J. E., & Magliano, D. J. (2024). The epidemiology of type 1 diabetes mellitus in older adults. Nature Reviews Endocrinology, 21(2), 92-104. https://doi.org/10.1038/s41574-024-01046-z

Grigoriadis, G., Koufakis, T., & Kotsa, K. (2023). Epidemiological, Pathophysiological, and clinical considerations on the interplay between thyroid disorders and type 2 diabetes mellitus. Medicina, 59(11), 2013. https://doi.org/10.3390/medicina59112013

Chauhan, A., & Patel, S. S. (2024). Thyroid hormone and diabetes mellitus interplay: Making management of comorbid disorders complicated. Hormone and Metabolic Research, 56(12), 845-858. https://doi.org/10.1055/a-2374-8756

Das, D., Banerjee, A., Jena, A. B., Duttaroy, A. K., & Pathak, S. (2022). Essentiality, relevance, and efficacy of adjuvant/combinational therapy in the management of thyroid dysfunctions. Biomedicine & Pharmacotherapy, 146, 112613. https://doi.org/10.1016/j.biopha.2022.112613

Sinha, S. H., Zietlow, K., & Papaleontiou, M. (2024). Thyroid function and cognitive decline: A narrative review. Endocrine Practice, 30(11), 1113-1118. https://doi.org/10.1016/j.eprac.2024.07.013

Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., Rinella, M. E., Vos, M. B., & Younossi, Z. (2022). American Association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings. Endocrine Practice, 28(5), 528-562. https://doi.org/10.1016/j.eprac.2022.03.010

Kotak, P. S., Kadam, A., Acharya, S., Kumar, S., & Varma, A. (2024). Beyond the thyroid: A narrative review of extra-thyroidal manifestations in Hashimoto’s disease. Cureus. https://doi.org/10.7759/cureus.71126

Shapiro, R. (2024). Bone health management through exercise in older adults with diabetes: patient perspectives and experiences. https://escholarship.mcgill.ca/concern/theses/gm80j2117

Lambrinoudaki, I., Paschou, S. A., Armeni, E., & Goulis, D. G. (2022). The interplay between diabetes mellitus and menopause: Clinical implications. Nature Reviews Endocrinology, 18(10), 608-622. https://doi.org/10.1038/s41574-022-00708-0

Wander, G. S., Panda, J. K., Pal, J., Mathur, G., Sahay, R., Tiwaskar, M., ... & Maheswari13, S. (2024). Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Indian Guideline 2024 by Association of Physicians of India and Indian College of Physicians. hypertension, 35, 2. https://journal-api.s3.ap-south-1.amazonaws.com/issues/articles/japi-72-8-e1.pdf

Downloads

Published

2025-02-28

How to Cite

Impact of Thyroid Dysregulation on Glycemic Control in Type 2 Diabetes Mellitus: A Comparative Investigation. (2025). Indus Journal of Bioscience Research, 3(2), 586-590. https://doi.org/10.70749/ijbr.v3i2.738